177 related articles for article (PubMed ID: 31995747)
1. Human pDCs Are Superior to cDC2s in Attracting Cytolytic Lymphocytes in Melanoma Patients Receiving DC Vaccination.
van Beek JJP; Flórez-Grau G; Gorris MAJ; Mathan TSM; Schreibelt G; Bol KF; Textor J; de Vries IJM
Cell Rep; 2020 Jan; 30(4):1027-1038.e4. PubMed ID: 31995747
[TBL] [Abstract][Full Text] [Related]
2. Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes.
Fu C; Peng P; Loschko J; Feng L; Pham P; Cui W; Lee KP; Krug AB; Jiang A
Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23730-23741. PubMed ID: 32879009
[TBL] [Abstract][Full Text] [Related]
3. Tumour-loaded α-type 1-polarized dendritic cells from patients with chronic lymphocytic leukaemia produce a superior NK-, NKT- and CD8+ T cell-attracting chemokine profile.
Gustafsson K; Junevik K; Werlenius O; Holmgren S; Karlsson-Parra A; Andersson PO
Scand J Immunol; 2011 Sep; 74(3):318-326. PubMed ID: 21595737
[TBL] [Abstract][Full Text] [Related]
4. Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells.
Van Acker HH; Beretta O; Anguille S; De Caluwé L; Papagna A; Van den Bergh JM; Willemen Y; Goossens H; Berneman ZN; Van Tendeloo VF; Smits EL; Foti M; Lion E
Oncotarget; 2017 Feb; 8(8):13652-13665. PubMed ID: 28099143
[TBL] [Abstract][Full Text] [Related]
5. Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3-dioxygenase 1 with functional effects on T cell priming.
Sittig SP; van Beek JJP; Flórez-Grau G; Weiden J; Buschow SI; van der Net MC; van Slooten R; Verbeek MM; Geurtz PBH; Textor J; Figdor CG; de Vries IJM; Schreibelt G
Eur J Immunol; 2021 Jun; 51(6):1494-1504. PubMed ID: 33675038
[TBL] [Abstract][Full Text] [Related]
6. IFN-alpha beta released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells.
Lande R; Giacomini E; Grassi T; Remoli ME; Iona E; Miettinen M; Julkunen I; Coccia EM
J Immunol; 2003 Feb; 170(3):1174-82. PubMed ID: 12538673
[TBL] [Abstract][Full Text] [Related]
7. CCR2- and Flt3-Dependent Inflammatory Conventional Type 2 Dendritic Cells Are Necessary for the Induction of Adaptive Immunity by the Human Vaccine Adjuvant System AS01.
Bosteels C; Fierens K; De Prijck S; Van Moorleghem J; Vanheerswynghels M; De Wolf C; Chalon A; Collignon C; Hammad H; Didierlaurent AM; Lambrecht BN
Front Immunol; 2020; 11():606805. PubMed ID: 33519816
[TBL] [Abstract][Full Text] [Related]
8. Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses.
Stolk DA; de Haas A; Vree J; Duinkerken S; Lübbers J; van de Ven R; Ambrosini M; Kalay H; Bruijns S; van der Vliet HJ; de Gruijl TD; van Kooyk Y
Front Immunol; 2020; 11():990. PubMed ID: 32536918
[TBL] [Abstract][Full Text] [Related]
9. Plasmacytoid dendritic cell heterogeneity is defined by CXCL10 expression following TLR7 stimulation.
Marsman C; Lafouresse F; Liao Y; Baldwin TM; Mielke LA; Hu Y; Mack M; Hertzog PJ; de Graaf CA; Shi W; Groom JR
Immunol Cell Biol; 2018 Nov; 96(10):1083-1094. PubMed ID: 29870118
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands.
Kohrgruber N; Gröger M; Meraner P; Kriehuber E; Petzelbauer P; Brandt S; Stingl G; Rot A; Maurer D
J Immunol; 2004 Dec; 173(11):6592-602. PubMed ID: 15557149
[TBL] [Abstract][Full Text] [Related]
11. Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells.
Sköld AE; Mathan TSM; van Beek JJP; Flórez-Grau G; van den Beukel MD; Sittig SP; Wimmers F; Bakdash G; Schreibelt G; de Vries IJM
Cancer Immunol Immunother; 2018 Sep; 67(9):1425-1436. PubMed ID: 30019146
[TBL] [Abstract][Full Text] [Related]
12. CXCR3 chemokine receptor contributes to specific CD8+ T cell activation by pDC during infection with intracellular pathogens.
Pontes Ferreira C; Moro Cariste L; Henrique Noronha I; Fernandes Durso D; Lannes-Vieira J; Ramalho Bortoluci K; Araki Ribeiro D; Golenbock D; Gazzinelli RT; Vasconcelos JRC
PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008414. PubMed ID: 32574175
[TBL] [Abstract][Full Text] [Related]
13. Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes.
Grover A; Kim GJ; Lizée G; Tschoi M; Wang G; Wunderlich JR; Rosenberg SA; Hwang ST; Hwu P
Clin Cancer Res; 2006 Oct; 12(19):5801-8. PubMed ID: 17020987
[TBL] [Abstract][Full Text] [Related]
14. Collapse of the Plasmacytoid Dendritic Cell Compartment in Advanced Cutaneous Melanomas by Components of the Tumor Cell Secretome.
Vescovi R; Monti M; Moratto D; Paolini L; Consoli F; Benerini L; Melocchi L; Calza S; Chiudinelli M; Rossi G; Bugatti M; Maio M; Fonsatti E; Farisoglio C; Simbolo M; Almici C; Verardi R; Scarpa A; Bergese P; Manganoni A; Facchetti F; Vermi W
Cancer Immunol Res; 2019 Jan; 7(1):12-28. PubMed ID: 30401679
[TBL] [Abstract][Full Text] [Related]
15. Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma.
Butterfield LH; Vujanovic L; Santos PM; Maurer DM; Gambotto A; Lohr J; Li C; Waldman J; Chandran U; Lin Y; Lin H; Tawbi HA; Tarhini AA; Kirkwood JM
J Immunother Cancer; 2019 Apr; 7(1):113. PubMed ID: 31014399
[TBL] [Abstract][Full Text] [Related]
16. Independent regulation of chemokine responsiveness and cytolytic function versus CD8+ T cell expansion by dendritic cells.
Watchmaker PB; Berk E; Muthuswamy R; Mailliard RB; Urban JA; Kirkwood JM; Kalinski P
J Immunol; 2010 Jan; 184(2):591-7. PubMed ID: 20018619
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
[TBL] [Abstract][Full Text] [Related]
18. Current State of Dendritic Cell-Based Immunotherapy: Opportunities for
Huber A; Dammeijer F; Aerts JGJV; Vroman H
Front Immunol; 2018; 9():2804. PubMed ID: 30559743
[TBL] [Abstract][Full Text] [Related]
19. Plasmacytoid dendritic cells, a role in neoplastic prevention and progression.
Lombardi VC; Khaiboullina SF; Rizvanov AA
Eur J Clin Invest; 2015 Jan; 45 Suppl 1():1-8. PubMed ID: 25524580
[TBL] [Abstract][Full Text] [Related]
20. DC-Based Vaccines for Cancer Immunotherapy.
Fu C; Zhou L; Mi QS; Jiang A
Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33255895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
